Entera Bio Stock Buy Hold or Sell Recommendation
| ENTX Stock | USD 2.07 0.15 6.76% |
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Entera Bio is 'Sell'. Macroaxis provides Entera Bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ENTX positions. The advice algorithm takes into account all of Entera Bio's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Entera Bio's buy or sell advice are summarized below:
Real Value 3.1 | Target Price 6 | Hype Value 1.85 | Market Value 2.07 | Naive Value 1.81 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Entera Bio given historical horizon and risk tolerance towards Entera Bio. When Macroaxis issues a 'buy' or 'sell' recommendation for Entera Bio, the advice is generated through an automated system that utilizes algorithms and statistical models.
Entera |
Execute Entera Bio Buy or Sell Advice
The Entera recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Entera Bio. Macroaxis does not own or have any residual interests in Entera Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Entera Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Solid | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Entera Bio Trading Alerts and Improvement Suggestions
| Entera Bio is way too risky over 90 days horizon | |
| Entera Bio appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 14 K. Net Loss for the year was (8.89 M) with profit before overhead, payroll, taxes, and interest of 33 K. | |
| Entera Bio currently holds about 17.28 M in cash with (7.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6. | |
| Entera Bio has a poor financial position based on the latest SEC disclosures | |
| Roughly 20.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Hillel Galitzer of 30151 shares of Entera Bio subject to Rule 16b-3 |
Entera Bio Returns Distribution Density
The distribution of Entera Bio's historical returns is an attempt to chart the uncertainty of Entera Bio's future price movements. The chart of the probability distribution of Entera Bio daily returns describes the distribution of returns around its average expected value. We use Entera Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Entera Bio returns is essential to provide solid investment advice for Entera Bio.
| Mean Return | 1.57 | Value At Risk | -10.71 | Potential Upside | 19.28 | Standard Deviation | 8.62 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Entera Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Entera Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Entera Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Entera Bio backward and forwards among themselves. Entera Bio's institutional investor refers to the entity that pools money to purchase Entera Bio's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Two Sigma Securities, Llc | 2023-12-31 | 69.4 K | Hightower Advisors, Llc | 2023-12-31 | 11.8 K | Knoll Capital Management Lp | 2023-12-31 | 0.0 | Advisor Group Holdings, Inc. | 2023-09-30 | 0.0 | Hrt Financial Llc | 2023-09-30 | 0.0 |
Entera Bio Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Investments | 3.9M | (86K) | (17K) | (102K) | (15K) | (15.8K) | |
| Change In Cash | 7.7M | (6.6M) | 16.3M | (12.6M) | (1.3M) | (1.2M) | |
| Free Cash Flow | (9.0M) | (10.5M) | (9.1M) | (12.5M) | (7.3M) | (7.7M) | |
| Depreciation | 238K | 225K | 53K | 64K | 56K | 97.3K | |
| Other Non Cash Items | (569K) | (1.2M) | 18K | (78K) | (507K) | (532.4K) | |
| Capital Expenditures | 68K | 40K | 53K | 17K | 47K | 16.2K | |
| Net Income | (10.8M) | (10.0M) | (12.2M) | (13.1M) | (8.9M) | (9.3M) | |
| End Period Cash Flow | 15.2M | 8.6M | 25.0M | 12.4M | 11.0M | 11.8M | |
| Change To Netincome | 783K | (314K) | 1.7M | 2.3M | 2.7M | 2.8M |
Entera Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Entera Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Entera Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Entera stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 1.42 | |
β | Beta against NYSE Composite | 1.56 | |
σ | Overall volatility | 8.69 | |
Ir | Information ratio | 0.17 |
Entera Bio Volatility Alert
Entera Bio is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Entera Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Entera Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Entera Bio Fundamentals Vs Peers
Comparing Entera Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Entera Bio's direct or indirect competition across all of the common fundamentals between Entera Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Entera Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Entera Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Entera Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Entera Bio to competition |
| Fundamentals | Entera Bio | Peer Average |
| Return On Equity | -0.8 | -0.31 |
| Return On Asset | -0.45 | -0.14 |
| Current Valuation | 62.11 M | 16.62 B |
| Shares Outstanding | 35.48 M | 571.82 M |
| Shares Owned By Insiders | 19.89 % | 10.09 % |
| Shares Owned By Institutions | 10.47 % | 39.21 % |
| Number Of Shares Shorted | 88.21 K | 4.71 M |
| Price To Earning | 2.10 X | 28.72 X |
| Price To Book | 10.18 X | 9.51 X |
| Price To Sales | 107.25 X | 11.42 X |
| Revenue | 14 K | 9.43 B |
| Gross Profit | 33 K | 27.38 B |
| EBITDA | (8.88 M) | 3.9 B |
| Net Income | (8.89 M) | 570.98 M |
| Cash And Equivalents | 17.28 M | 2.7 B |
| Cash Per Share | 0.60 X | 5.01 X |
| Total Debt | 390 K | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 10.89 X | 2.16 X |
| Book Value Per Share | 0.29 X | 1.93 K |
| Cash Flow From Operations | (7.31 M) | 971.22 M |
| Short Ratio | 0.40 X | 4.00 X |
| Earnings Per Share | (0.31) X | 3.12 X |
| Target Price | 10.0 | |
| Number Of Employees | 17 | 18.84 K |
| Beta | 1.71 | -0.15 |
| Market Capitalization | 78.77 M | 19.03 B |
| Total Asset | 11.77 M | 29.47 B |
| Retained Earnings | (104.39 M) | 9.33 B |
| Working Capital | 10.17 M | 1.48 B |
| Current Asset | 8.46 M | 9.34 B |
| Current Liabilities | 7.64 M | 7.9 B |
| Net Asset | 11.77 M |
Note: Acquisition by Hillel Galitzer of 30151 shares of Entera Bio subject to Rule 16b-3 [view details]
Entera Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Entera . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Entera Bio Buy or Sell Advice
When is the right time to buy or sell Entera Bio? Buying financial instruments such as Entera Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 302K | 91K | 390K | 370.5K | Total Assets | 26.0M | 13.1M | 11.8M | 13.9M |
Use Investing Ideas to Build Portfolios
In addition to having Entera Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Real Estate Thematic Idea Now
Real Estate
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Real Estate theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Entera Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Entera Stock analysis
When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Entera Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entera Bio. If investors know Entera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entera Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.31) | Quarterly Revenue Growth (0.92) | Return On Assets (0.45) | Return On Equity (0.80) |
The market value of Entera Bio is measured differently than its book value, which is the value of Entera that is recorded on the company's balance sheet. Investors also form their own opinion of Entera Bio's value that differs from its market value or its book value, called intrinsic value, which is Entera Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entera Bio's market value can be influenced by many factors that don't directly affect Entera Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Entera Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Entera Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entera Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.